Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Clasificación en acciones #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Precio por acción
$11.03
Última sincronización: 2026-08-28
Capitalización bursátil
$597.15M
Cambio (1 día)
-4.25%
Cambio (1 año)
-
País
US
Comercio Eikon Therapeutics, Inc. Common Stock (EIKN)

Categoría

Historial del precio de la acción de Eikon Therapeutics, Inc. Common Stock (EIKN)
Precio más alto de cierre: $10.87 el 2026-08-01

Precio más bajo de cierre: $14.75 el 2026-02-01
Historial del precio de la acción de Eikon Therapeutics, Inc. Common Stock desde 2026 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
Not enough data for the provided dates.
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$542.09 38.63%
US
$1.03K 44.13%
NL
$120.75 -13.26%
AU
$138.18 473.58%
US
$759.27 7.20%
CH